eisai co ltd (4523:Tokyo Stock Exchange)
Chief Executive Officer, Representative Corporate Officer and Director, Eisai Co., Ltd.
|Age||Total Calculated Compensation||This person is connected to 11 board members in 1 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Haruo Naito has been Chief Executive Officer of Eisai Co. Ltd. at Eisai, Inc. since June 2003 and has been its Representative Corporate Officer since June 2004. Mr. Naito has been President of Genox Research, Inc. since March 1996 and Drug Delivery System Institute, Ltd. since June 2003. He joined Eisai Co. Ltd. in October 1975 and became its Managing Director in June 1985; Representative Director and Senior Managing Director in June 1986; and Deputy President in ...
4-6-10, KoishikawaPhone: 81 3 3817 3700
Tokyo, -- 112-8088
Board Members Memberships*
Chief Executive Officer, Representative Corporate Officer and Director
Education*There is no Education data available.
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|Thomas W. D'Alonzo Esq., J.D.||Chairman, Acting Chief Executive Officer, Acting President, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee|
Salix Pharmaceuticals Ltd.
|Akira Kurokawa||Chief Executive Officer, President, Director, Member of Nominating Committee, Member of Executive Compensation Committee and Member of Corporate Strategy Committee|
Santen Pharmaceutical Co. Ltd.
|Eduardo Javier Sanchiz Yrazu||Chief Executive Officer, Chief Executive of Corporate Development & Finance, Executive Director, Member of Management Board and Member of Compliance Committee|
|Richard Martin Steeves Ph.D.||Group Chief Executive Officer, Member of Senior Executive Board and Executive Director|
Synergy Health plc
|823.0K GBP||Compensation as of Fiscal Year 2013.|